PieriniLab's profile picture. Hematologist. Bone Marrow Transplant specialist. Life enthusiast. Passionate about science. Junior Faculty @ University of Perugia.

Antonio Pierini

@PieriniLab

Hematologist. Bone Marrow Transplant specialist. Life enthusiast. Passionate about science. Junior Faculty @ University of Perugia.

Antonio Pierini reposted

Truly honoured to receive the 5th EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2025! It’s been a fantastic #CART25 congress in Strasbourg! @EHA_Hematology @TheEBMT

ValentinOrtizMD's tweet image. Truly honoured to receive the 5th EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2025! It’s been a fantastic #CART25 congress in Strasbourg! @EHA_Hematology @TheEBMT
ValentinOrtizMD's tweet image. Truly honoured to receive the 5th EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2025! It’s been a fantastic #CART25 congress in Strasbourg! @EHA_Hematology @TheEBMT
ValentinOrtizMD's tweet image. Truly honoured to receive the 5th EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2025! It’s been a fantastic #CART25 congress in Strasbourg! @EHA_Hematology @TheEBMT

It was a privilege to be part of a fantastic #ash24 educational session on leukemia relapse after hsct together with ⁦@vago_luca⁩ and Sawa Ito.

PieriniLab's tweet image. It was a privilege to be part of a fantastic #ash24 educational session on leukemia relapse after hsct together with ⁦@vago_luca⁩ and Sawa Ito.

Biology of post-transplant relapse: actionable features | Hematology, ASH Education Program | American Society of Hematology ashpublications.org/hematology/art…


Antonio Pierini reposted

Really wonderful talk as usual @vago_luca Congratulations for your amazing work! #ASH24

Tom_Perini's tweet image. Really wonderful talk as usual @vago_luca 
Congratulations for your amazing work!
#ASH24

Antonio Pierini reposted

A dream that is already a reality! A true team effort! Thanks to all that have made it possible!! 💥💥🎉🎉

🚀 Exciting news! Introducing the new EBMT Registry 🌐 A result of dedicated teamwork, this innovative platform replaces ProMISe and Castor, streamlining data management for a better user experience. 📊🤝 #EBMTRegistry @AnnaSureda5 Learn more ⬇️ ebmt.org/registry/ebmt-…

TheEBMT's tweet image. 🚀 Exciting news! Introducing the new EBMT Registry 🌐 A result of dedicated teamwork, this innovative platform replaces ProMISe and Castor, streamlining data management for a better user experience. 📊🤝 #EBMTRegistry @AnnaSureda5 

Learn more ⬇️
ebmt.org/registry/ebmt-…


Very nice and interesting work at #ASH22 cannot wait for the manuscript!

Does #BMT age the hematopoietic system? Yes, by 5-10 years, as estimated by loss of clonal diversity. Also interesting that only ~30K stem cells engraft on average. Great one, @doctor_msc 🙏 Fascinating fundamental work, with implications for donor selection. 👇 #ASH22

sghmd's tweet image. Does #BMT age the hematopoietic system?

Yes, by 5-10 years, as estimated by loss of clonal diversity.

Also interesting that only ~30K stem cells engraft on average.

Great one, @doctor_msc 🙏

Fascinating fundamental work, with implications for donor selection. 👇

#ASH22
sghmd's tweet image. Does #BMT age the hematopoietic system?

Yes, by 5-10 years, as estimated by loss of clonal diversity.

Also interesting that only ~30K stem cells engraft on average.

Great one, @doctor_msc 🙏

Fascinating fundamental work, with implications for donor selection. 👇

#ASH22
sghmd's tweet image. Does #BMT age the hematopoietic system?

Yes, by 5-10 years, as estimated by loss of clonal diversity.

Also interesting that only ~30K stem cells engraft on average.

Great one, @doctor_msc 🙏

Fascinating fundamental work, with implications for donor selection. 👇

#ASH22
sghmd's tweet image. Does #BMT age the hematopoietic system?

Yes, by 5-10 years, as estimated by loss of clonal diversity.

Also interesting that only ~30K stem cells engraft on average.

Great one, @doctor_msc 🙏

Fascinating fundamental work, with implications for donor selection. 👇

#ASH22


Antonio Pierini reposted

Congress | #ASH22 @charliecraddock Queen Elizabeth Hospital, Birmingham, delivers a fascinating talk on MRD in AML and how it can affect transplant decision-making. They highlight the impact of MRD positivity on conditioning regimens, stem cell source, and maintenance therapy.

AML_Hub's tweet image. Congress | #ASH22 @charliecraddock Queen Elizabeth Hospital, Birmingham, delivers a fascinating talk on MRD in AML and how it can affect transplant decision-making. They highlight the impact of MRD positivity on conditioning regimens, stem cell source, and maintenance therapy.
AML_Hub's tweet image. Congress | #ASH22 @charliecraddock Queen Elizabeth Hospital, Birmingham, delivers a fascinating talk on MRD in AML and how it can affect transplant decision-making. They highlight the impact of MRD positivity on conditioning regimens, stem cell source, and maintenance therapy.
AML_Hub's tweet image. Congress | #ASH22 @charliecraddock Queen Elizabeth Hospital, Birmingham, delivers a fascinating talk on MRD in AML and how it can affect transplant decision-making. They highlight the impact of MRD positivity on conditioning regimens, stem cell source, and maintenance therapy.
AML_Hub's tweet image. Congress | #ASH22 @charliecraddock Queen Elizabeth Hospital, Birmingham, delivers a fascinating talk on MRD in AML and how it can affect transplant decision-making. They highlight the impact of MRD positivity on conditioning regimens, stem cell source, and maintenance therapy.

So cool to present last clinical data at #ASH2022.

PieriniLab's tweet image. So cool to present last clinical data at #ASH2022.

La ricerca di Antonio Pierini punta a rendere più efficace il trapianto di midollo. L’approccio descritto in uno studio finanziato da #AIRC ha ottenuto un aumento della sopravvivenza a 2 anni dal trapianto, dal 20 al 70 per cento. #ricerca bit.ly/3h27kc8



Antonio Pierini reposted

From this months' #StemCellEvidence Alert: Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for #AML @PieriniLab in @BloodAdvances stemcellevidence.com/article/3364630 #BMT #leusm

evidencestemc's tweet image. From this months' #StemCellEvidence Alert: Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for #AML  @PieriniLab in @BloodAdvances 
stemcellevidence.com/article/3364630 #BMT #leusm

Cool! #science

“Begin universe. Wait three minutes to enter. Stay cool. Don’t react.” Which #ChemHaiku is your favorite? fcld.ly/h0ju4z5 #HaikuPoetryDay



Antonio Pierini reposted

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia ow.ly/Kpnk50DN0VV #AML

BloodAdvances's tweet image. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia ow.ly/Kpnk50DN0VV #AML

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia ashpublications.org/bloodadvances/…… Hard work, but finally out! A new transplant option for our patients! So proud! #transplant #Treg #AML #leukemia

PieriniLab's tweet image. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia ashpublications.org/bloodadvances/…… 
Hard work, but finally out! A new transplant option for our patients! So proud! #transplant #Treg #AML #leukemia

Nuovo progetto AIRC per la lotta alle leucemie trgmedia.it/Nuovo-progetto… via @arquennet


Antonio Pierini reposted
DrMvandenBrink's tweet image.

Congrats guys! Nice piece of work! #CARTcells

It feels a bit superfluous in the middle of a pandemic storm, but still happy that our paper on our early experience on academic #CARTcells (ARI-0001 cells) production finally got published! @immunoclinicbcn @hematoclinicbcn @hospitalclinic frontiersin.org/article/10.338…



It is so hard to face! #COVID2019 #bmtsm

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage ⁦@BMTjournal#bmtsm #COVID-19 #COVID19 #coronavirus nature.com/articles/s4140…



Loading...

Something went wrong.


Something went wrong.